Steroid pills and cell transplant for stable vitiligo
Part of Skin clinical trials.
This trial tests whether adding short bursts of steroid pills to a skin cell transplant procedure can improve results for people with stable vitiligo on hard-to-treat areas like elbows and knees.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have vitiligo patches on your elbows or knees that haven't gotten better with standard creams or light therapy.
- Your vitiligo has been stable for at least 1 year (no new spots or growth).
- You are 18 years or older.
- You have not used any creams on the area for at least 1 month, and no pills or injections for vitiligo for at least 3 months.
- You are not pregnant, and do not have high blood pressure, diabetes, or tuberculosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking small doses of steroids by mouth for a few days before and after a skin cell transplant (NCES) can reduce the white halo that sometimes forms around the treated area. It is for people with stable vitiligo on the face or trunk that hasn't responded to creams or light therapy.
This study tests whether applying a strong steroid cream (betamethasone) with the help of ultrasound waves (phonophoresis) can repigment vitiligo patches. It aims to see if this combination works better than the cream alone.
This trial tests a surgery that uses your own skin cells to treat stable vitiligo patches. It may help when creams or light therapy haven't worked.
This trial tests a daily pill (upadacitinib) to see if it can improve vitiligo after an initial treatment (NECS). It is for people whose vitiligo is stable and covers a limited area.
This Phase 2 trial tests whether a new drug called D-2570 can help restore skin color in people with non-segmental vitiligo (when white patches appear randomly across the body). The study will track how well the drug works and check if it's safe to use.
This trial tests a new gel made from stem-cell substances (secretome) given with narrow-band UVB light therapy for stable non-segmental vitiligo. It compares two ways of applying the gel to see which works better.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.